1. Home
  2. AIXI vs TARA Comparison

AIXI vs TARA Comparison

Compare AIXI & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.51

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$5.22

Market Cap

165.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIXI
TARA
Founded
2001
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
165.5M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AIXI
TARA
Price
$0.51
$5.22
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$20.40
AVG Volume (30 Days)
226.4K
1.3M
Earning Date
12-26-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,314,315.00
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.84
N/A
52 Week Low
$0.45
$2.77
52 Week High
$6.65
$7.82

Technical Indicators

Market Signals
Indicator
AIXI
TARA
Relative Strength Index (RSI) 30.27 41.28
Support Level $0.45 $5.03
Resistance Level $0.67 $6.37
Average True Range (ATR) 0.06 0.40
MACD -0.00 -0.18
Stochastic Oscillator 13.86 10.43

Price Performance

Historical Comparison
AIXI
TARA

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Share on Social Networks: